Relapses and lymphocyte counts before and after rescue therapy in the phase III, 96-week, double-blind, placebocontrolled CLARITY study of cladribine tablets for relapsing-remitting multiple sclerosis

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2011
This article has no abstract
Epistemonikos ID: 6d4788f5f394b00520206e59bd2e1d63afda8339
First added on: Apr 30, 2026